Wide Ranks

CRON

Cronos Group Inc. Common Share

2.08

Top Statistics
Market Cap 799 M Forward PE -7.46 Revenue Growth 46.00 %
Current Ratio 28.29 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins -56.43 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA 0.3280 Enterprise / Revenue -0.1980 Price To Sales Trailing12 Months 7.86
Profitability
Profit Margins -56.43 % Operating Margins -54.08 %
Balance Sheet
Total Cash 848 M Total Cash Per Share 2.22 Total Debt 1 M
Total Debt To Equity 0.1890 Current Ratio 28.29 Book Value Per Share 2.88
All Measures
Short Ratio 507.00 % Message Board Id finmb_253038643 Shares Short Prior Month 4 M
Return On Equity -0.0529 City Toronto Uuid c16afd87-8f99-3c59-851c-860ea909059d
Previous Close 2.09 First Trade Date Epoch Utc 1 B Book Value 2.88
Beta 1.01 Total Debt 1 M Volume 564188
Price To Book 0.7212 Fifty Two Week Low 1.85 Total Cash Per Share 2.22
Total Revenue 101 M Shares Short Previous Month Date 1 B Target Median Price 2.84
Audit Risk 4 Max Age 86400 Sand P52 Week Change 0.3133
Operating Margins -54.08 % Target Mean Price 3.18 Net Income To Common -57374000
Short Percent Of Float 0.0195 Implied Shares Outstanding 384 M Trailing Peg Ratio None
Last Fiscal Year End 1 B Average Daily Volume10 Day 945180 Average Volume10days 945180
Total Cash 848 M Next Fiscal Year End 1 B Revenue Per Share 0.2670
Held Percent Insiders 0.4640 Ebitda Margins -60.44 % Trailing PE 0.0000
Date Short Interest 1 B Most Recent Quarter 1 B Share Holder Rights Risk 6
Regular Market Previous Close 2.09 Target Low Price 2.79 Gmt Off Set Milliseconds -18000000
Fifty Day Average 2.14 Open 2.09 Free Cashflow -30522250
State ON Dividend Yield 0.00 % Return On Assets -0.0373
Time Zone Short Name EST Board Risk 8 Trailing Eps -0.1200
Day Low 2.07 Address1 111 Peter Street Shares Outstanding 382 M
Compensation Risk 10 Price Hint 4 Target High Price 3.91
Website https://www.thecronosgroup.com 52 Week Change 0.0297 Average Volume 1 M
Forward Eps -0.0400 Recommendation Key none Compensation As Of Epoch Date 1 B
Quick Ratio 2652.30 % Is_sp_500 False Regular Market Day High 2.13
Profit Margins -56.43 % Debt To Equity 0.1890 Fifty Two Week High 3.14
Day High 2.13 Shares Short 3 M Regular Market Open 2.09
Industry Key drug-manufacturers-specialty-generic Earnings Growth 0.00 % Enterprise To Revenue -0.1980
Revenue Growth 46.00 % Shares Percent Shares Out 0.0102 Operating Cashflow 16 M
Currency USD Time Zone Full Name America/New_York Market Cap 799 M
Is_nasdaq_100 False Zip M5V 2H1 Quote Type EQUITY
Industry Drug Manufacturers - Specialty & Generic Long Name Cronos Group Inc. Overall Risk 8
Regular Market Day Low 2.07 Held Percent Institutions 0.1562 Current Price 2.08
Address2 Suite 300 Enterprise To Ebitda 0.3280 Financial Currency USD
Current Ratio 28.29 Gross Margins 16.37 % Industry Disp Drug Manufacturers - Specialty & Generic
Number Of Analyst Opinions 3 Country Canada Float Shares 203 M
Two Hundred Day Average 2.34 Governance Epoch Date 1 B Enterprise Value -20168826
Price To Sales Trailing12 Months 7.86 Forward PE -7.46 Regular Market Volume 564188
Ebitda -61510000 Exchange NGM
Go to Yahoo Finance Go to Seeking Alpha 
Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany.

It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands.

Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.